Neurophysiological biomarkers using transcranial magnetic stimulation in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis
- 1 February 2021
- journal article
- review article
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 121, 47-59
Abstract
No abstract availableKeywords
Funding Information
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
This publication has 104 references indexed in Scilit:
- The potential role of dopamine D3 receptor neurotransmission in cognitionEuropean Neuropsychopharmacology, 2013
- Inhibitory Neuron and Hippocampal Circuit Dysfunction in an Aged Mouse Model of Alzheimer's DiseasePLOS ONE, 2013
- Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer’s diseaseProceedings of the National Academy of Sciences, 2012
- MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's diseaseNeuroImage, 2012
- Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive ControlBiological Psychiatry, 2011
- Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networksNature Neuroscience, 2010
- Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5Neuron, 2010
- Inhibition of Calcineurin-mediated Endocytosis and α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Prevents Amyloid β Oligomer-induced Synaptic DisruptionJournal of Biological Chemistry, 2010
- Dopamine in Motor Cortex Is Necessary for Skill Learning and Synaptic PlasticityPLOS ONE, 2009
- Cholinergic Neuronal and Axonal Abnormalities Are Present Early in Aging and in Alzheimer DiseaseJournal of Neuropathology & Experimental Neurology, 2008